The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception · 2026
Perimenopausal hot flashes do not depend on crude circulating oestradiol levels: further evidences from women treated with oral GnRH antagonists combination therapy for symptomatic fibroids.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Grandi Giovanni, Barretta Marta, Iaccheri Mattia, Versailles Jacques Berthold Evens, La Marca Antonio
Аннотация
PURPOSE: Some perimenopausal women treated for fibroid-related bleeding may already experience hot flashes.
MATERIALS AND METHODS: In this pilot case series, we evaluated the effect of relugolix combination therapy (relugolix 40 mg + oestradiol 1 mg + norethisterone acetate 0.5 mg) on hot flashes and endocrine parameters in seven perimenopausal women.
RESULTS: All women reported a marked improvement (visual analogue scale: 8.6 ± 1.0) of hot flashes, while treatment significantly suppressed FSH (p = 0.004), LH (p = 0.002) and oestradiol (p = 0.002) serum levels.
CONCLUSIONS: These preliminary findings indicate that hot flashes improvement may not depend on crude circulating oestradiol levels in perimenopausal women, but probably on their stabilisation with the oral GnRH antagonist addition.
MATERIALS AND METHODS: In this pilot case series, we evaluated the effect of relugolix combination therapy (relugolix 40 mg + oestradiol 1 mg + norethisterone acetate 0.5 mg) on hot flashes and endocrine parameters in seven perimenopausal women.
RESULTS: All women reported a marked improvement (visual analogue scale: 8.6 ± 1.0) of hot flashes, while treatment significantly suppressed FSH (p = 0.004), LH (p = 0.002) and oestradiol (p = 0.002) serum levels.
CONCLUSIONS: These preliminary findings indicate that hot flashes improvement may not depend on crude circulating oestradiol levels in perimenopausal women, but probably on their stabilisation with the oral GnRH antagonist addition.